Phenasen®, Arsenic Trioxide, 10mg In 10ml, Injection Phebra Pty Ltd Chemwatch Hazard Alert Code: 4 Chemwatch: 23-0970 Issue Date: 10/07/2017 Version No: 6.1.1.1 Print Date: 02/03/2018 Safety Data Sheet according to WHS and ADG requirements S.GHS.AUS.EN SECTION 1 IDENTIFICATION OF THE SUBSTANCE / MIXTURE AND OF THE COMPANY / UNDERTAKING Product Identifier Product name Phenasen®, Arsenic Trioxide, 10mg In 10ml, Injection Synonyms Not Available Other means of identification Not Available Relevant identified uses of the substance or mixture and uses advised against Phenasen injection is for the treatment of acute promyelocytic leukaemia where treatment with all-trans retinoic acid and anthracycline chemotherapy has Relevant identified uses failed or where the patient has relapsed. Details of the supplier of the safety data sheet Registered company name Phebra Address 19 Orion Road Lane Cove West NSW 2066 Australia Telephone +61 2 9420 9199|1800 720 020 Fax +61 2 9420 9177 Website www.phebra.com Email
[email protected] Emergency telephone number Association / Organisation Not Available Emergency telephone numbers +61 401 264 004 Other emergency telephone N/A numbers SECTION 2 HAZARDS IDENTIFICATION Classification of the substance or mixture Poisons Schedule S4 Classification [1] Acute Toxicity (Oral) Category 4, Acute Toxicity (Inhalation) Category 4, Carcinogenicity Category 1A Legend: 1. Classified by Chemwatch; 2. Classification drawn from HSIS ; 3. Classification drawn from EC Directive 1272/2008 - Annex VI Label elements Hazard pictogram(s) SIGNAL WORD DANGER Hazard statement(s) H302 Harmful if swallowed. H332 Harmful if inhaled. H350 May cause cancer. Precautionary statement(s) Prevention P201 Obtain special instructions before use.